(1)
High Dosage of Prostate-Specific Antigen (PSA) in a Patient After Radical Prostatectomy and Without Clinical Evidence to Support Tumor Recurrence: Case Report. RSD 2021, 10 (13), e93101321104. https://doi.org/10.33448/rsd-v10i13.21104.